A systems methodology to assess the risk of tumor relapse in melanoma by the profiling of plasma extracellular vesicles (MelEVIR)
Third Party Funds Group - Sub project
Acronym:
MelEVIR
Start date :
01.04.2016
End date :
31.03.2019
Extension date:
31.05.2020
